ArticleHuman vaccines & immunotherapeutics2024
Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years.
Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Population-level prevalence and risk of oral HPV infection with or without HPV vaccination.Human vaccines & immunotherapeutics · 2026Article
- Trends in HPV vaccination among adults aged 27-45 years in the United States.Human vaccines & immunotherapeutics · 2026Article
- HPV vaccine coverage among adults aged 27-45: Implications for oropharyngeal cancer prevention.Human vaccines & immunotherapeutics · 2026Article
- Unmet Social Needs and HPV Vaccination Among Parents and Children Residing in a Major Metropolitan Area.Journal of racial and ethnic health disparities · 2026Article
- Knowledge, Attitudes, and Behaviors Regarding HPV Vaccination and Self-Sampling Among US Young Adults.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026Article
- Cancer Screening Uptake and Usual Source of Care Among Hispanic Survivors of Adolescent and Young Adult Cancer.Journal of adolescent and young adult oncology · 2026Article
- Factors Associated With Frequency and Hours of Daily Hearing Aid Use in the United States.Laryngoscope investigative otolaryngology · 2026Article
- Article
- Baseline characteristics of the HOMINY (human papillomavirus, human immunodeficiency virus, and oral microbiota interplay in Nigerian youth) prospective longitudinal cohort.Frontiers in oral health · 2026Article
- Article
- Education and social determinants shaping HPV vaccine uptake: Insights from a nationwide cross-sectional study.Human vaccines & immunotherapeutics · 2025Article
- The role of dentists in promoting human papillomavirus vaccination for oropharyngeal cancer prevention: A cross-sectional survey of dentists in North Carolina.Journal of the American Dental Association (1939) · 2025Article
- Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity.Lancet regional health. Americas · 2025Review
- The importance of parental human papillomavirus vaccine series initiation for reducing sex disparities in human papillomavirus vaccine series initiation among children in the United States.Preventive medicine reports · 2025Article
- Factors associated with human papillomavirus (HPV) patient-clinician communication and HPV vaccine uptake among adults in the United States.Preventive medicine · 2025Article
- HPV Vaccination Knowledge and Decision-Making Among Adults 27 to 45 Years: A Large Online Survey.Laryngoscope investigative otolaryngology · 2025Article
- Quantifying the impact of introducing HPV vaccines in 2006 on 25-29-year-old cervical cancer incidence in 2022.JNCI cancer spectrum · 2025Article
- What cancers explain the growing rural-urban gap in human papillomavirus-associated cancer incidence?The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025Article
- Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.PloS one · 2025Article
- Comment on "Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27-45 years".Human vaccines & immunotherapeutics · 2024Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
In 2018, the Food and Drug Administration expanded the age of eligibility for the human papillomavirus (HPV) vaccine to 27 to 45 years. However, it is unclear if there are racial/ethnic disparities in HPV vaccine uptake for this age-group following this expanded recommendation. We aimed to identify any disparities in HPV vaccine in 27 to 45 year-olds based on sociodemographic factors. We analyzed nationally representative, cross-sectional data from the 2019 National Health Interview Survey (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.